Johnson & Johnson (JNJ) is a leader in the pharmaceutical, medical device and consumer products industries. A household name company, JNJ runs a globally diversified business with mature business segments. A dividend payer and grower for 52 years, the company has made a lot of investors very rich and happy over the decades. As the global population ages, the demand for healthcare rises significantly and companies such as JNJ stand to benefit handsomely. This article evaluates the financials and presents a complete dividend stock analysis of Johnson & Johnson.